Control de tabaco Press Releases
WASHINGTON, DC -- In public comments jointly filed today, 24 leading public health and medical organizations called on the Food and Drug Administration to issue a final rule to regul
WASHINGTON, D.C. July 21, 2014 Following is a statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), in reaction to a Florida jury award of $23 billion in punitive damages to widow Cynthia Robinson in her lawsuit against R.J.
WASHINGTON, D.C. June 24, 2014 The Centers for Disease Control and Prevention (CDC) released new advertisements today as part of its ongoing Tips from Former Smokers national campaign. The following is a statement from John R.
WASHINGTON, DC On the fifth anniversary of the landmark 2009 law granting the Food and Drug Administration (FDA) authority over tobacco products, 10 leading public health and medical organizations today commended the FDA for the steps it has taken to reduce tobacco use and called on the FDA and
WASHINGTON, D.C. June 12, 2014 The Centers for Disease Control and Prevention (CDC) today released results from the Youth Risk Behavior Surveillance (YRBS) survey showing youth cigarette use has declined to 15.7 percent, a historic low.
WASHINGTON, DC – U.S. District Judge Gladys Kessler on Monday issued a final order detailing how major U.S.
Following is a statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), on the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing today on the state of tobacco regulation by the Food & Drug Administration (FDA).
An article posted today in the New England Journal of Medicine confirms what public health advocates have suspected for decades that chemicals used to flavor popular candies and drinks are strikingly similar to those used to flavor tobacco products that are designed to addict kids.
The information issued today provides much-needed clarity to plans and insurers on what constitutes a comprehensive tobacco cessation benefit under the Affordable Care Act.
WASHINGTON, D.C. April 24, 2014 Following is a statement from John R. Seffrin, chief executive of the American Cancer Society Cancer Action Network (ACS CAN), on the deeming regulation issued today by the Food & Drug Administration (FDA):